Page last updated: 2024-11-06

phentolamine and Dental Pulp Diseases

phentolamine has been researched along with Dental Pulp Diseases in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Dental Pulp Diseases: Endodontic diseases of the DENTAL PULP inside the tooth, which is distinguished from PERIAPICAL DISEASES of the tissue surrounding the root.

Research Excerpts

ExcerptRelevanceReference
"Phentolamine has been reported to be an effective local anesthetic reversal agent for soft tissue but has not been studied in endodontics."2.76Reversal of soft-tissue anesthesia in asymptomatic endodontic patients: a preliminary, prospective, randomized, single-blind study. ( Beck, M; Drum, M; Fowler, S; Nusstein, J; Reader, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fowler, S1
Nusstein, J1
Drum, M1
Reader, A1
Beck, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phentolamine Mesylate as a Reversal of Local Anesthesics[NCT03740386]90 participants (Actual)Interventional2016-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for phentolamine and Dental Pulp Diseases

ArticleYear
Reversal of soft-tissue anesthesia in asymptomatic endodontic patients: a preliminary, prospective, randomized, single-blind study.
    Journal of endodontics, 2011, Volume: 37, Issue:10

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period

2011